Your browser doesn't support javascript.
loading
The Oncolytic Herpes Simplex Virus Talimogene Laherparepvec Shows Promising Efficacy in Neuroendocrine Cancer Cell Lines.
Kloker, Linus D; Berchtold, Susanne; Smirnow, Irina; Schaller, Martin; Fehrenbacher, Birgit; Krieg, Andreas; Sipos, Bence; Lauer, Ulrich M.
Afiliación
  • Kloker LD; Department of Clinical Tumor Biology, University Hospital, University of Tübingen, Tübingen, Germany.
  • Berchtold S; Department of Clinical Tumor Biology, University Hospital, University of Tübingen, Tübingen, Germany.
  • Smirnow I; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Tübingen, Germany.
  • Schaller M; Department of Clinical Tumor Biology, University Hospital, University of Tübingen, Tübingen, Germany.
  • Fehrenbacher B; Department of Dermatology, University Hospital, University of Tübingen, Tübingen, Germany.
  • Krieg A; Department of Dermatology, University Hospital, University of Tübingen, Tübingen, Germany.
  • Sipos B; Department of Surgery (A), Heinrich-Heine-University and University Hospital Düsseldorf, Düsseldorf, Germany.
  • Lauer UM; Department of Clinical Tumor Biology, University Hospital, University of Tübingen, Tübingen, Germany.
Neuroendocrinology ; 109(4): 346-361, 2019.
Article en En | MEDLINE | ID: mdl-31280274

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Productos Biológicos / Tumores Neuroendocrinos / Virus Oncolíticos / Viroterapia Oncolítica Límite: Humans Idioma: En Revista: Neuroendocrinology Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Productos Biológicos / Tumores Neuroendocrinos / Virus Oncolíticos / Viroterapia Oncolítica Límite: Humans Idioma: En Revista: Neuroendocrinology Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza